---
title: "ROYALTY PHARMA HOLDINGS LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/67717511-ed32-5ba9-bf8e-c10b70d6ce2a
json: https://whiteintel.dev/api/public/dossier/67717511-ed32-5ba9-bf8e-c10b70d6ce2a
identifier: oo:GB-COH-12453789
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ROYALTY PHARMA HOLDINGS LTD

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-12453789`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/67717511-ed32-5ba9-bf8e-c10b70d6ce2a  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/67717511-ed32-5ba9-bf8e-c10b70d6ce2a  

## Cross-source identity

The same real-world entity, resolved across sources:

- **ROYALTY PHARMA HOLDINGS LTD** — GLEIF · `lei:5493006XF0G5DI9BTR42` — https://whiteintel.dev/entity/d366721d-3d14-5827-98aa-6be1be0ce95f

## Ownership & control

### Owners / controllers

- **ROYALTY PHARMA PLC** (beneficial owner) — 100% — https://whiteintel.dev/entity/a58c1100-4bc2-5c94-8772-7f733e2fceef
- **ROYALTY PHARMA PLC** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/a58c1100-4bc2-5c94-8772-7f733e2fceef

### UBO chain (walk to the ultimate owner)

A **6-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `12453789`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2020-02-10
- **Registered office:** The Pavilions, Bridgwater Road, Bristol, BS13 8AE, England
- **SIC:** 96090

### Officers

- COYNE, Terrance — director · American · appointed 2020-06-10
- LEGORRETA, Pablo — director · American · appointed 2020-02-10
- MCGIVERN, Arthur — director · American · appointed 2026-01-01
- [VISTRA COSEC LIMITED](https://whiteintel.dev/entity/c0d53d7b-482f-52f7-af62-7e36b80f875b) — corporate secretary · appointed 2020-02-10 · resigned 2020-06-05
- LLOYD, George Wingate — director · American · appointed 2020-06-10 · resigned 2025-12-31

### Beneficial owners (Persons with Significant Control)

- [Royalty Pharma Plc](https://whiteintel.dev/entity/a58c1100-4bc2-5c94-8772-7f733e2fceef) — 75–100% shares · corporate PSC · England — since 2020-02-10

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/12453789
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/12453789

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **ROYALTY PHARMA HOLDINGS LTD** — https://whiteintel.dev/entity/67717511-ed32-5ba9-bf8e-c10b70d6ce2a · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ROYALTY PHARMA HOLDINGS LTD**. Human view: https://whiteintel.dev/entity/67717511-ed32-5ba9-bf8e-c10b70d6ce2a · Structured JSON: https://whiteintel.dev/api/public/dossier/67717511-ed32-5ba9-bf8e-c10b70d6ce2a._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._